Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations

Aerpio Pharmaceuticals, Inc. to acquire Aadi Bioscience, Inc.

Announced May 16, 2021 · Closed Aug 27, 2021 · Private target

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock

Transaction

Acquirer
Aerpio Pharmaceuticals, Inc. (ARPO)
Target
Aadi Bioscience, Inc.
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Aug 27, 2021

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Ladenburg Thalmann
To the target
Perella Weinberg, Piper Sandler

Classification

Sector
Healthcare
Buyer's industry
Pharmaceutical Preparations
Sources
  • 8-K (EX-99.1) · May 17, 2021
  • DEFA14A (EX-99.1) · May 17, 2021

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.